p53

Correlation between p53 and epidermal growth factor receptor expression in breast cancer classification

X. Z. Wang, Liu, Q., Sun, J. J., Zuo, W. S., Hu, D. W., Ma, S. G., Mu, D. B., and Yu, Z. Y., “Correlation between p53 and epidermal growth factor receptor expression in breast cancer classification”, vol. 14, pp. 4282-4290, 2015.

This study aimed to explore new opportunities for developing targeted therapy for triple-negative breast cancer (TNBC) by analyzing the significance and association between p53 and epidermal growth factor receptor (EGFR) expression in different molecular subtypes of breast cancer. The clinical and pathological data of 264 patients with breast cancer receiving surgery in our hospital from January 2012 to August 2013 were retrospectively analyzed.

Analysis of TP53 gene expression and p53 level of human hypopharyngeal FaDu (HTB-43) head and neck cancer cell line after microRNA-181a inhibition

Y. K. Cheah, Cheng, R. W., Yeap, S. K., Khoo, C. H., and See, H. S., “Analysis of TP53 gene expression and p53 level of human hypopharyngeal FaDu (HTB-43) head and neck cancer cell line after microRNA-181a inhibition”, vol. 13, pp. 1679-1683, 2014.

The identification of new biomarkers for early detection of highly recurrent head and neck cancer is urgently needed. MicroRNAs (miRNAs) are small and non-coding RNAs that regulate cancer-related gene expression, such as tumor protein 53 (TP53) gene expression. This study was carried out to analyze TP53 gene expression using real-time PCR and to determine changes in intracellular p53 level by flow cytometry after downregulation of miRNA-181a miRNA inhibitor in the FaDu cell line.

TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population

C. M. Camargo-Kosugi, D’Amora, P., Kleine, J. P. F. O., Carvalho, C. V., Sato, H., Schor, E., and Silva, I. D. C. G., “TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population”, vol. 13, pp. 6503-6511, 2014.

We evaluated the association between TP53 gene polymorphisms and endometriosis in Brazilian women. Genomic DNA was extracted from swabs of buccal cells collected from hospital patients. TP53 gene polymorphisms were investigated at three codons: TP53*11 Glu/Gln or Lys (GAG->CAG or AAG), TP53*72 Arg/Pro (CCG->CCC), and TP53*248 Arg/Thr (CGG->TCG) using the polymerase chain reaction-restriction fragment length polymorphism method.

Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma

J. N. Zhang, Yi, S. H., Zhang, X. H., Liu, X. Y., Mao, Q., Li, S. Q., Xiong, W. H., Qiu, Y. M., Chen, T., and Ge, J. W., “Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma”, vol. 11, pp. 3618-3628, 2012.

Epidemiological studies of the association of variants p53 Arg72Pro and MDM2 single-nucleotide polymorphism 309 (SNP309) with glioma risk have produced inconsistent results. The aim of the current study was to evaluate the association of these 2 variants with glioma susceptibility using a meta-analysis approach. For p53 Arg72Pro, 10 case-control studies including 2587 glioma patients and 4061 unrelated controls were identified.

Involvement of CYP1A1, GST, 72TP53 polymorphisms in the pathogenesis of thyroid nodules

A. A. S. Reis, Silva, D. M., Curado, M. P., and da Cruz, A. D., “Involvement of CYP1A1, GST, 72TP53 polymorphisms in the pathogenesis of thyroid nodules”, vol. 9, pp. 2222-2229, 2010.

Specific genotypes appear to be related to the development of thyroid disease. We examined whether polymorphisms of the genes CYP1A1, GSTM1, GSTT1, and TP53 at codon 72 are associated with increased risk for thyroid nodules. Blood samples were obtained from 122 thyroid patients with nodules and from 134 healthy control individuals from Goiânia city, GO, Brazil. We found no significant association of CYP1A1m1 and CYP1A1m2 genotypes with thyroid diseases (P > 0.05).

Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray

Y. Ye, Wang, D., Su, C., Rong, T., and Guo, A., “Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray”, vol. 8, pp. 1509-1518, 2009.

Mutations of some contributing factors (p53, p16, Rb, and EGFR) are believed to affect diagnosis and drug resistance of lung cancer. We evaluated the efficacy of a multimarker panel for molecular diagnosis of lung cancer, using a high-throughput suspension microarray. One hundred and twenty-five lung cancer specimens and 30 tumor-free lung tissue samples were assayed by multiplex polymerase chain reaction with specific probes designed to detect hot-spot mutations in p53, p16, Rb, and EGFR.

Correlation of aberrant expression of p53, Rad50, and cyclin-E proteins with microsatellite instability in gallbladder adenocarcinomas

P. K. Mishra, Jatawa, S. K., Raghuram, G. V., Pathak, N., Jain, A., Tiwari, A., Varshney, S., and Maudar, K. K., “Correlation of aberrant expression of p53, Rad50, and cyclin-E proteins with microsatellite instability in gallbladder adenocarcinomas”, vol. 8, pp. 1202-1210, 2009.

Gallbladder carcinoma is an uncommon, but highly malignant tumor, with poor prognostic, and diagnostic manifestations in early stages. The Indian Council of Medical Research reported increased incidence of gallbladder carcinoma in the surviving population of the Bhopal gas tragedy that involved exposure of more than 500,000 people to methyl isocyanate gas. The severity of exposure, and increased multi-systemic morbidity in the survivors stimulated us to examine the molecular changes leading to gallbladder carcinoma.